Recruiting A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults NCT06680128 Conditions Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more Locations Nucleus Network - Brisbane (Q Pharm) — Brisbane, Australia Nucleus Network - Melbourne — Melbourne, Australia New Zealand Clinical Research — Christchurch, Central City, New Zealand View Trial Details
Completed Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in Toddlers NCT01396512 Conditions Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +18 more Locations Goyang, South Korea Incheon, South Korea Seongnam, South Korea Seoul, South Korea View more locations Show fewer locations Loading locations... View Trial Details
